Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease

Neurobiology of Aging

Volumn 34, Issue 3, 2013, Pages 873-886

  Reyes, Stefanie ^a   Fu, Yuhong ^a   Double, Kay L ^a   Cottam, Veronica ^a   Thompson, Lachlan H ^b   Kirik, Deniz ^c   Paxinos, George ^a   Watson, Charles ^a,d   Cooper, Helen M ^e   Halliday, Glenda M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c LUND UNIVERSITY   (Sweden)

^d CURTIN UNIVERSITY   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Deleted in colorectal cancer; Dopamine neurons; Orthodenticle homeobox 2; Pitx3; Substantia nigra

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR PITX3;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CELL DIFFERENTIATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; SUPERIOR COLLICULUS; UBIQUITINATION; VENTRAL TEGMENTUM;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANIMALS; DOPAMINERGIC NEURONS; FEMALE; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MIDDLE AGED; OTX TRANSCRIPTION FACTORS; PARKINSON DISEASE; RECEPTORS, CELL SURFACE; SUBSTANTIA NIGRA; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VENTRAL TEGMENTAL AREA;

EID: 84870514012     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.07.019     Document Type: Article

References (57)

1. Andersson E., Tryggvason U., Deng Q., Friling S., Alekseenko Z., Robert B., Perlmann T., Ericson J. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 2006, 124:393-405.
2. Bäckman C., Perlmann T., Wallén A., Hoffer B.J., Morales M. A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain Res 1999, 851:125-132.
3. Bergman O., Håkansson A., Westberg L., Nordenström K., Carmine Belin A., Sydow O., Olson L., Holmberg B., Eriksson E., Nissbrandt H. PITX3 polymorphism is associated with early onset Parkinson's disease. Neurobiol. Aging 2010, 31:114-117.
4. Bradford D., Cole S.J., Cooper H.M. Netrin-1: diversity in development. Int. J. Biochem. Cell Biol 2009, 41:487-493.
5. Chu Y., Kompoliti K., Cochran E.J., Mufson E.J., Kordower J.H. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J. Comp. Neurol 2002, 450:203-214.
6. Chu Y., Kordower J.H. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?. Neurobiol. Dis 2007, 25:134-149.
7. Chung C.Y., Licznerski P., Alavian K.N., Simeone A., Lin Z., Martin E., Vance J., Isacson O. The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons. Brain 2010, 133:2022-2031.
8. Chung C.Y., Seo H., Sonntag K.C., Brooks A., Lin L., Isacson O. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum. Mol. Genet 2005, 14:1709-1725.
9. Cotrufo T., Perez-Branguli F., Muhaisen A., Ros O., Andres R., Baeriswyl T., Fuschini G., Tarrago T., Pascual M., Urena J., Blasi J., Giralt E., Stoeckli E.T., Soriano E. A signaling mechanism coupling netrin-1/deleted in colorectal cancer chemoattraction to SNARE-mediated exocytosis in axonal growth cones. J. Neurosci 2011, 31:14463-14480.
10. Darios F., Ruipérez V., López I., Villanueva J., Gutierrez L.M., Davletov B. Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep 2010, 11:528-533.
11. Di Salvio M., Di Giovannantonio L.G., Acampora D., Prosperi R., Omodei D., Prakash N., Wurst W., Simeone A. Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP. Nat. Neurosci 2010, 13:1481-1488.
12. Di Salvio M., Di Giovannantonio L.G., Omodei D., Acampora D., Simeone A. Otx2 expression is restricted to dopaminergic neurons of the ventral tegmental area in the adult brain. Int. J. Dev. Biol 2010, 54:939-945.
13. Dickson D.W., Braak H., Duda J.E., Duyckaerts C., Gasser T., Halliday G.M., Hardy J., Leverenz J.B., Del Tredici K., Wszolek Z.K., Litvan I. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009, 8:1150-1157.
14. Double K.L., Reyes S., Werry E.L., Halliday G.M. Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?. Prog. Neurobiol 2010, 92:316-329.
15. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
16. Franklin K., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, Elsevier Academic Press, San Diego.
17. Fuchs J., Mueller J.C., Lichtner P., Schulte C., Munz M., Berg D., Wüllner U., Illig T., Sharma M., Gasser T. The transcription factor PITX3 is associated with sporadic Parkinson's disease. Neurobiol. Aging 2009, 30:731-738.
18. Gad J.M., Keeling S.L., Shu T., Richards L.J., Cooper H.M. The spatial and temporal expression patterns of netrin receptors, DCC and neogenin, in the developing mouse retina. Exp. Eye Res 2000, 70:711-722.
19. Garcia-Reitbock P., Anichtchik O., Bellucci A., Iovino M., Ballini C., Fineberg E., Ghetti B., Della Corte L., Spano P., Tofaris G.K., Goedert M., Spillantini M.G. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain J. Neurol 2010, 133:2032-2044.
20. Gibb W.R., Lees A.J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1991, 54:388-396.
21. Greene J.G., Dingledine R., Greenamyre J.T. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. Neurobiol. Dis 2005, 18:19-31.
22. Halliday G., Reyes S., Double K. Substantia nigra, ventral tegmental area and retrorubral fields. The Human Nervous System 2012, 439-455. Academic Press, London. J.K. Mai, G. Paxinos (Eds.).
23. Hwang D.Y., Ardayfio P., Kang U.J., Semina E.V., Kim K.S. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Res. Mol. Brain Res 2003, 114:123-131.
24. Kim H.J. Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons. Biochim. Biophys. Acta 2011, 1812:1-11.
25. Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., Hannon G., Abeliovich A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317:1220-1224.
26. Korotkova T.M., Ponomarenko A.A., Haas H.L., Sergeeva O.A. Differential expression of the homeobox gene Pitx3 in midbrain dopaminergic neurons. Eur. J. Neurosci 2005, 22:1287-1293.
27. Le W., Nguyen D., Lin X.W., Rawal P., Huang M., Ding Y., Xie W., Deng H., Jankovic J. Transcription factor PITX3 gene in Parkinson's disease. Neurobiol. Aging 2011, 32:750-753.
28. Lebel M., Gauthier Y., Moreau A., Drouin J. Pitx3 activates mouse tyrosine hydroxylase promoter via a high-affinity binding site. J. Neurochem 2001, 77:558-567.
29. Lesnick T.G., Papapetropoulos S., Mash D.C., Ffrench-Mullen J., Shehadeh L., De Andrade M., Henley J.R., Rocca W.A., Ahlskog J.E., Maraganore D.M. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 2007, 3:e98.
30. Lin L., Lesnick T.G., Maraganore D.M., Isacson O. Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. Trends Neurosci 2009, 32:142-149.
31. Manitt C., Mimee A., Eng C., Pokinko M., Stroh T., Cooper H.M., Kolb B., Flores C. The netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry. J. Neurosci 2011, 31:8381-8394.
32. Matsuda W., Furuta T., Nakamura K.C., Hioki H., Fujiyama F., Arai R., Kaneko T. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J. Neurosci 2009, 29:444-453.
33. Mcritchie D.A., Hardman C.D., Halliday G.M. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J. Comp. Neurol 1996, 364:121-150.
34. Nagahara A.H., Tuszynski M.H. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat. Rev. Drug Discov 2011, 10:209-219.
35. Lai Wing Sun K., Correia J.P., Kennedy T.E. Netrins: versatile extracellular cues with diverse functions. Development 2011, 138:2153-2169.
36. Nunes I., Tovmasian L.T., Silva R.M., Burke R.E., Goff S.P. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4245-4250.
37. Orme R., Fricker-Gates R.A., Gates M.A. Ontogeny of substantia nigra dopamine neurons. Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra 2009, Springer, Wien, New York. G. Di Giovanni, V. Di Matteo, E. Esposito (Eds.).
38. Osborne P.B., Halliday G.M., Cooper H.M., Keast J.R. Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents. Neuroscience 2005, 131:671-681.
39. Paxinos G., Huang X. Atlas of the Human Brainstem 1995, Academic Press, Washington, DC.
40. Prensa L., Parent A. The nigrostriatal pathway in the rat: A single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments. J. Neurosci 2001, 21:7247-7260.
41. Rangasamy S.B., Soderstrom K., Bakay R.A., Kordower J.H. Neurotrophic factor therapy for Parkinson's disease. Prog. Brain Res 2010, 184:237-264.
42. Reyes S., Fu Y., Double K., Thompson L., Kirik D., Paxinos G., Halliday G.M. GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area. J. Comp. Neurol 2012, 520:2591-2607.
43. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P., Conneely O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:4013-4018.
44. Shatzmiller R.A., Goldman J.S., Simard-Emond L., Rymar V., Manitt C., Sadikot A.F., Kennedy T.E. Graded expression of netrin-1 by specific neuronal subtypes in the adult mammalian striatum. Neuroscience 2008, 157:621-636.
45. Simeone A., Di Salvio M., Di Giovannantonio L.G., Acampora D., Omodei D., Tomasetti C. The role of otx2 in adult mesencephalic-diencephalic dopaminergic neurons. Mol. Neurobiol 2011, 43:107-113.
46. Simon H.H., Bhatt L., Gherbassi D., Sgadó P., Alberí L. Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. Ann. N. Y. Acad. Sci 2003, 991:36-47.
47. Simon H.H., Saueressig H., Wurst W., Goulding M.D., O'Leary D.D. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci 2001, 21:3126-3134.
48. Smidt M.P., Burbach J.P. How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci 2007, 8:21-32.
49. Smidt M.P., Smits S.M., Bouwmeester H., Hamers F.P., Van Der Linden A.J., Hellemons A.J., Graw J., Burbach J.P. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 2004, 131:1145-1155.
50. Smidt M.P., Van Schaick H.S., Lanctôt C., Tremblay J.J., Cox J.J., Van Der Kleij A.A., Wolterink G., Drouin J., Burbach J.P. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13305-13310.
51. Sullivan A.M., Toulouse A. Neurotrophic factors for the treatment of Parkinson's disease. Cytokine Growth Factor Rev 2011, 22:157-165.
52. Tcherkezian J., Brittis P.A., Thomas F., Roux P.P., Flanagan J.G. Transmembrane receptor DCC associates with protein synthesis machinery and regulates translation. Cell 2010, 141:632-644.
53. Thomas M. Role of transcription factors in cell replacement therapies for neurodegenerative conditions. Regen. Med 2010, 5:441-450.
54. Van Den Munckhof P., Luk K.C., Ste-Marie L., Montgomery J., Blanchet P.J., Sadikot A.F., Drouin J. Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 2003, 130:2535-2542.
55. Xu B., Goldman J.S., Rymar V.V., Forget C., Lo P.S., Bull S.J., Vereker E., Barker P.A., Trudeau L.E., Sadikot A.F., Kennedy T.E. Critical roles for the netrin receptor deleted in colorectal cancer in dopaminergic neuronal precursor migration, axon guidance, and axon arborization. Neuroscience 2010, 169:932-949.
56. Yang D., Peng C., Li X., Fan X., Li L., Ming M., Chen S., Le W. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures. J. Neurosci. Res 2008, 86:3393-3400.
57. Zhao S., Maxwell S., Jimenez-Beristain A., Vives J., Kuehner E., Zhao J., O'Brien C., De Felipe C., Semina E., Li M. Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons. Eur. J. Neurosci 2004, 19:1133-1140.